Genevant Sciences and Arbutus Biopharma File Patent Infringement Lawsuit Against ModernaGlobeNewsWire • 02/28/22
Moderna CEO says the pandemic will end this year, but new Omicron-specific boosters may be neededBusiness Insider • 02/25/22
Moderna up nearly 15% on strong quarterly results: here's what you should nowThe Dog of Wall Street • 02/24/22
Moderna Rallies After Q4 Earnings: What 2 Analysts Have To Say About COVID-19 StockBenzinga • 02/24/22
Will Moderna Be 'One Of The Most Valuable Healthcare Companies' In The World? Steve Weiss Believes SoBenzinga • 02/24/22
Moderna, Inc. (MRNA) CEO Stéphane Bancel on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 02/24/22
Nasdaq Stages Epic Intraday Recovery After Russia Invades Ukraine; Adobe, Moderna Lead BoostBenzinga • 02/24/22